London, UK-based biotechnology startup on a mission to revolutionize the agricultural industry by giving crops the genetic tools to defend themselves against disease, Resurrect Bio, raised GBP 1.61 million in seed financing. The round took place on May 16, 2023. SynBioVen led the financing for the company. Meanwhile, UKI2S, AgFunder and SHAKE Climate Change Accelerator joined in the seed investment.

Purpose of financing for Resurrect Bio 

With the latest financing from the seed round, Resurrect Bio seeks to accelerate product development.

It also has plans to strengthen its underlying disease-resistance trait-discovery platform.

What the company’s officials have to add

Dr Cian Duggan, CEO of Resurrect Bio, said, “Resurrect Bio is thrilled to have secured this investment from such a strong group of partners who share our vision of delivering disease-resistant crops to farmers. This funding will enable us to accelerate our mission and make significant strides towards more sustainable agriculture.”

What the investors have to add 

Antoine Pechin from SynBioVen, further said, “We’re very excited to partner with the Resurrect Bio team. Their unique technology not only reduces the use of agrichemicals, but it also helps increase crop yields and thereby contributes to addressing the growing food security issues the world is facing.”

In addition, Oliver Sexton, Investment Director UKI2S, commented, “The fund backs world-changing technology at an early stage, and Resurrect Bio is a great example of that ambition. Its platform will lead to reduced pesticide use, and UKI2S is delighted to help Cian and the team build their technology.”

About the company 

Dr Cian Duggan and Dr Tolga Bozkurt launched the company. The London-based biotech startup is a spin-out company of The Sainsbury Laboratory in Norwich. The company is developing a platform that leverages gene editing techniques to fix the innate immune system of crops and make crops more resistant to disease. The process is critical in order to reduce the use of agrichemicals while feeding an increasing world population.

Resurrect Bio leverages the latest scientific discoveries, integrating a unique blend of computational biology, Artificial Intelligence (AI), and synthetic biology methods to rapidly identify and resurrect native disease-resistance genes in crops. In addition, the company partners with key members of the seed industry to enable the rapid delivery of gene-edited disease-resistant seeds. It further enables farmers with the option to enhance their crop yield and reduce their dependence on agrichemicals.

For more extensive analysis and Market Intelligence reports, feel free to approach us.

We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know

if there are any discrepancies in any of our published stories,

-how we can improve,

-what stories you would like us to cover

–what information you are looking for in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!

Next Article

Previous articleSingapore-based AnotherBall raises USD 2.2 million in recent financing 
Next articleNew York-based AI startup Laguna Health raises USD 15 in Series A funding
Jasleen Bhatia works as a content writer for VCBay News. She is pursuing her final semester in Bachelor of Business Administration from IIPS, DAVV. Driven by her keen interest in entrepreneurship and finance, she writes business-related articles.


Please enter your comment!
Please enter your name here